ENZB logo

Enzo Biochem Stock Price

Symbol: OTCPK:ENZBMarket Cap: US$35.9mCategory: Pharmaceuticals & Biotech

ENZB Share Price Performance

ENZB Community Fair Values

    Recent ENZB News & Updates

    No updates

    Enzo Biochem, Inc. Key Details

    US$27.5m

    Revenue

    US$15.7m

    Cost of Revenue

    US$11.8m

    Gross Profit

    US$19.6m

    Other Expenses

    -US$7.8m

    Earnings

    Last Reported Earnings
    Apr 30, 2025
    Next Reporting Earnings
    n/a
    Earnings per share (EPS)
    -0.15
    Gross Margin
    42.83%
    Net Profit Margin
    -28.54%
    Debt/Equity Ratio
    0.5%

    Enzo Biochem, Inc. Competitors

     
     
     
     
     
     
     
     
     
     
     
     

    About ENZB

    Founded
    1976
    Employees
    131
    CEO
    Kara Cannon
    WebsiteView website
    www.enzo.com

    Enzo Biochem, Inc., a life sciences company, engages in the labeling and detection technologies from DNA to whole cell analysis in the United States and internationally. The company offers labels, dyes, antibodies, genomic probes, immunoassays, biochemicals, and proteins are used to label, detect, and visualize a biological target of interest in drug discovery exploration and drug development process development. Its proprietary products and technologies play roles in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. The company licenses its technology. It serves academic researchers, clinical researchers, biotechnology and pharmaceutical companies, and diagnostic manufacturers. Enzo Biochem, Inc. was incorporated in 1976 and is headquartered in Farmingdale, New York.

    U.S. Market Performance

    • 7 Days: -0.6%
    • 3 Months: 11.8%
    • 1 Year: 16.8%
    • Year to Date: 7.5%
    Over the last 7 days, the market has remained flat, although notably the Healthcare sector declined by 4.2%. Meanwhile, the market is actually up 17% over the past year. Earnings are forecast to grow by 15% annually. Market details ›
    This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
    Continue reading